This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pradax Class Action

TORONTO, April 10, 2013 /CNW/ - Toronto law firm McPhadden Samac Tuovi LLP has commenced a proposed national class action against Boehringer Ingelheim relating to the blood thinner Pradax. The lawsuit is on behalf of all persons throughout Canada who ingested Pradax.

The claim is for damages in the amount of $150,000,000.

Pradax is used to prevent clotting in patients who suffer from atrial fibrillation (a condition in which the heart beats irregularly, increasing the chance of clots forming in the body and possibly causing strokes).  It is also used by patients who have had hip and knee surgery.

There have been reports that Pradax causes excessive bleeding.  There is no antidote that can be taken to stop excessive bleeding that might be caused by Pradax.  Bleeding caused by the drug that Pradax was intended to replace, Warfarin, can easily be stopped using a simple administration of vitamin K.

In the lawsuit, it is the plaintiff's position that patients should have been warned about the lack of an antidote.  Claims are also made on behalf of others who say they suffered harm because of Pradax.

SOURCE McPhadden Samac Tuovi LLP

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs